The Latest Breaking News from Johnson & Johnson (

Exclusive: ideas include reducing trial safeguards and allowing startups to harvest patient data

Months into a complex trial over their role in flooding Washington with highly addictive painkillers, the nation’s three largest opioid distributors have agreed to pay the state $518 million

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 400 points on Tuesday.

Johnson & Johnson (NYSE: JNJ) shares are trading higher Tuesday after the company reported mixed financial results and increased its dividend.

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year

Johnson & Johnson (NYSE:JNJ) has reported Q1 FY22 adjusted earnings of $2.67 per share, up 3.1% Y/Y and ahead of the consensus of $2.61. Net sales increased 5% Y/Y (7.9% on an operational basis) to $23.43 billion, missing the consensus of $23.67 billion. Pharmaceuticals contributed $12.87 billion in sales, +9.3%, due to Darzalex…

  Johnson & Johnson (NYSE:JNJ) reported its Q1 earnings results on Tuesday, April 19, 2022 at 06:30 AM. Here's what investors need to know about the announcement.